Entity Details

Primary name SCYL1_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ96KG9
EntryNameSCYL1_HUMAN
FullNameN-terminal kinase-like protein
TaxID9606
Evidenceevidence at protein level
Length808
SequenceStatuscomplete
DateCreated2006-09-19
DateModified2021-06-02

Ontological Relatives

GenesSCYL1

GO terms

Show/Hide Table
GOName
GO:0003677 DNA binding
GO:0004713 protein tyrosine kinase activity
GO:0005524 ATP binding
GO:0005634 nucleus
GO:0005737 cytoplasm
GO:0005793 endoplasmic reticulum-Golgi intermediate compartment
GO:0005794 Golgi apparatus
GO:0005801 cis-Golgi network
GO:0005815 microtubule organizing center
GO:0005829 cytosol
GO:0006890 retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum
GO:0006954 inflammatory response
GO:0016020 membrane
GO:0021522 spinal cord motor neuron differentiation
GO:0030126 COPI vesicle coat
GO:0034613 cellular protein localization
GO:0045296 cadherin binding
GO:0048666 neuron development

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm
Endoplasmic reticulum-Golgi intermediate compartment
Golgi apparatus
Nucleus

Domains

Show/Hide Table
DomainNameCategoryType
IPR000719 Protein kinase domainDomainDomain
IPR011009 Protein kinase-like domain superfamilyFamilyHomologous superfamily
IPR011989 Armadillo-like helicalFamilyHomologous superfamily
IPR016024 Armadillo-type foldFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
616719 OMIMSpinocerebellar ataxia, autosomal recessive, 21 (SCAR21)A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR21 is characterized by cerebellar atrophy and ataxia with onset in early childhood. Patients also manifest recurrent episodes of liver failure, hepatic fibrosis and a peripheral neuropathy. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB05036 Grn163lDrugbanksmall molecule

Interactions

28 interactions

InteractorPartnerSourcesPublicationsLink
SCYL1_HUMANCOIL_HUMANBioGRID, HPRD, IntAct16713569 details
SCYL1_HUMANMPIP1_HUMANBioGRID, IntAct21988832 details
SCYL1_HUMANCHD1L_HUMANBioGRID, IntAct21988832 details
SCYL1_HUMANGORAB_HUMANBioGRID, HPRD, IntAct12783284 21988832 30631079 details
SCYL1_HUMANAXIN1_HUMANBioGRID, IntAct26871637 details
SCYL1_HUMANDDX6_HUMANBioGRID, IntAct32296183 details
SCYL1_HUMANPKHF2_HUMANBioGRID, IntAct32296183 details
SCYL1_HUMANLENG1_HUMANBioGRID, IntAct32296183 details
SCYL1_HUMANTCEA2_HUMANBioGRID, IntAct32296183 details
SCYL1_HUMANPIN1_HUMANBioGRID, IntAct32296183 details
SCYL1_HUMANDAPK1_HUMANBioGRID, IntAct29513927 details
SCYL1_HUMANA4_HUMANBioGRID21832049 details
SCYL1_HUMANC1QR1_HUMANBioGRID, HPRD15459234 details
SCYL1_HUMANCCNF_HUMANBioGRID25980818 details
SCYL1_HUMANSMUF1_HUMANBioGRID20804422 details
SCYL1_HUMANNOD2_HUMANBioGRID27812135 details
SCYL1_HUMANSCYL1_HUMANBioGRID, HPRD12783284 30631079 details
SCYL1_HUMANCOPB_HUMANBioGRID30631079 details
SCYL1_HUMANCOPG1_HUMANBioGRID30631079 details
SCYL1_HUMANCOPA_HUMANBioGRID30631079 details
SCYL1_HUMANCOPE_HUMANBioGRID30631079 details
SCYL1_HUMANCOPD_HUMANBioGRID30631079 details
SCYL1_HUMANARF1_HUMANBioGRID30631079 details
SCYL1_HUMANARF3_HUMANBioGRID30631079 details
SCYL1_HUMANNEK7_HUMANBioGRID, IntAct27173435 unassigned1312 details
SCYL1_HUMANP4HA2_HUMANBioGRID, IntAct27173435 unassigned1312 details
SCYL1_HUMANREST_HUMANBioGRID25453754 details
SCYL1_HUMANCOPB2_HUMANBioGRID30631079 details